Search research articles
Contact Us
Filters
Showing results (1-10 of 199) with videos related to
Page
of 20
Sort By:
Current Drug Targets
|
August 24, 2017
Editorial: New Potential Targets for the Treatment of Biliary Diseases
Jesus M Banales
Journal of Hepatology
|
February 12, 2022
PIGR-enriched circulating vesicles contributes to hepatocellular carcinoma aggressiveness
Alessandra Zingoni, Jesus M Banales
Cellular and Molecular Gastroenterology and Hepatology
|
March 24, 2023
PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
Paula Olaizola, Jesus M Banales
Nature Reviews. Gastroenterology & Hepatology
|
May 5, 2021
Applications of organoids in regenerative medicine: a proof-of-concept for biliary injury
Pedro M Rodrigues, Jesus M Banales
Journal of Hepatology
|
July 29, 2021
Reply to: "We need to talk about #livertwitter"
Elliot B Tapper, Jesus M Banales
Cellular and Molecular Gastroenterology and Hepatology
|
October 8, 2020
Characterizing the Heterogeneity of Liver Cell Populations Under a NASH-Related Hepatotoxicant Using Single-Nuclei RNA Sequencing
Pedro M Rodrigues, Jesus M Banales
Journal of Hepatology
|
February 7, 2018
Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications
Juliane I Beier, Jesus M Banales
Alimentary Pharmacology & Therapeutics
|
December 31, 2021
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet?
Pedro M Rodrigues, Jesus M Banales
Journal of Hepatology
|
November 9, 2025
RePARylating biliary tumours to improve the efficacy of chemoimmunotherapy
Pedro M Rodrigues, Jesus M Banales
Hepatology (Baltimore, Md.)
|
August 8, 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary strictures
Jesus M Banales, Ainhoa Lapitz, Luca Fabris
Page
of 20
Search research articles
Search
Showing results (1-10 of 199) with videos related to
Sort By:
Page
of 20
Current Drug Targets
|
August 24, 2017
Editorial: New Potential Targets for the Treatment of Biliary Diseases
Jesus M Banales
Journal of Hepatology
|
February 12, 2022
PIGR-enriched circulating vesicles contributes to hepatocellular carcinoma aggressiveness
Alessandra Zingoni, Jesus M Banales
Cellular and Molecular Gastroenterology and Hepatology
|
March 24, 2023
PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
Paula Olaizola, Jesus M Banales
Nature Reviews. Gastroenterology & Hepatology
|
May 5, 2021
Applications of organoids in regenerative medicine: a proof-of-concept for biliary injury
Pedro M Rodrigues, Jesus M Banales
Journal of Hepatology
|
July 29, 2021
Reply to: "We need to talk about #livertwitter"
Elliot B Tapper, Jesus M Banales
Cellular and Molecular Gastroenterology and Hepatology
|
October 8, 2020
Characterizing the Heterogeneity of Liver Cell Populations Under a NASH-Related Hepatotoxicant Using Single-Nuclei RNA Sequencing
Pedro M Rodrigues, Jesus M Banales
Journal of Hepatology
|
February 7, 2018
Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications
Juliane I Beier, Jesus M Banales
Alimentary Pharmacology & Therapeutics
|
December 31, 2021
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet?
Pedro M Rodrigues, Jesus M Banales
Journal of Hepatology
|
November 9, 2025
RePARylating biliary tumours to improve the efficacy of chemoimmunotherapy
Pedro M Rodrigues, Jesus M Banales
Hepatology (Baltimore, Md.)
|
August 8, 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary strictures
Jesus M Banales, Ainhoa Lapitz, Luca Fabris
Page
of 20